See more : OrthoPediatrics Corp. (KIDS) Income Statement Analysis – Financial Results
Complete financial analysis of National Graphite Corp. (NGRC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Graphite Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Lattice Semiconductor Corporation (LSCC) Income Statement Analysis – Financial Results
- Valtes Co., Ltd. (4442.T) Income Statement Analysis – Financial Results
- GCC, S.A.B. de C.V. (GCWOF) Income Statement Analysis – Financial Results
- India Nippon Electricals Limited (INDNIPPON.BO) Income Statement Analysis – Financial Results
- Texas Capital Bancshares, Inc. (TCBIO) Income Statement Analysis – Financial Results
National Graphite Corp. (NGRC)
Industry: Shell Companies
Sector: Financial Services
About National Graphite Corp.
National Graphite Corp., through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company. The company collaborates with clinical stage companies that develop new biological entities or new therapeutically platforms for the treatment of various diseases, rare diseases, and diseases with unmet needs. It is developing a drug candidate called ELAFIN, which is a human identic protein for the treatment of postoperative inflammatory complications. National Graphite Corp. has a collaboration agreement with Proteo Inc. for developing ELAFIN. The company was formerly known as Lucky Boy Silver Corporation and changed its name to National Graphite Corp. in May 2012. National Graphite Corp. was founded in 2006 and is based in Duesseldorf, Germany.
| Metric | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 107.85K | 27.32K | 28.83K | 5.00K | 0.00 | 30.00K |
| Gross Profit | 0.00 | 0.00 | -107.85K | -27.32K | -28.83K | -5.00K | 0.00 | -30.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.02M | 91.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.15K | 3.42 | 239.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.15M | 3.41K | 239.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.15M | 3.42K | 239.26K | 347.42K | 572.12K | 202.01K | 51.11K | 26.31K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.17M | 94.62K | 240.07K | 348.23K | 572.39K | 202.01K | 51.11K | 26.31K |
| Cost & Expenses | 2.17M | 94.62K | 347.92K | 375.55K | 601.21K | 207.01K | 51.11K | 56.31K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 59.17K | 10.79K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 583.36 | 541.00 | 809.00 | 808.00 | 270.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -1.91M | -94.62K | -518.48K | -374.74K | -658.44K | -264.51K | -51.11K | -56.31K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.17M | -94.62K | -519.29K | -375.55K | -543.71K | -149.51K | -51.11K | -56.31K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 199.29K | -33.80K | 0.00 | 0.00 | -57.50K | -57.50K | 0.00 | 0.00 |
| Income Before Tax | -1.97M | -128.42K | -519.29K | -375.55K | -658.71K | -264.51K | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 58.59K | 10.25K | 171.37K | 0.00 | 57.50K | 0.00 | 51.11K | 56.31K |
| Net Income | -1.97M | -128.42K | -519.29K | -375.55K | -658.71K | -264.51K | -51.11K | -56.31K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -24.90 | -0.01 | -0.22 | -0.16 | -0.17 | -0.06 | -0.01 | -0.02 |
| EPS Diluted | -24.90 | -0.01 | -0.22 | -0.15 | -0.17 | -0.06 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 79.06K | 25.00M | 2.37M | 2.37M | 3.78M | 4.53M | 4.45M | 3.45M |
| Weighted Avg Shares Out (Dil) | 79.06K | 25.00M | 2.37M | 2.48M | 3.78M | 4.53M | 4.45M | 3.45M |
Source: https://incomestatements.info
Category: Stock Reports